
MedChemExpress - Model Tolperisone hydrochloride - 3644-61-9
Tolperisone hydrochloride is a centrally acting muscle relaxant studied in neurological disorders causing pathological rhabdomyosclerosis (pyramidal tract injury, multiple sclerosis, myelopathy, encephalomyelitis), spastic paralysis, and other muscle dystonia-related Encephalopathy. Tolperisone hydrochloride also has antiviral activity[1].MCE products for research use only. We do not sell to patients.
Tolperisone hydrochloride
MCE China:Tolperisone hydrochloride
Brand:MedChemExpress (MCE)
Cat. No.HY-B1139
CAS:3644-61-9
Purity:99.94%
Storage:4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Shipping:Room temperature in continental US; may vary elsewhere.
Description:Tolperisone hydrochloride is a centrally acting muscle relaxant studied in neurological disorders causing pathological rhabdomyosclerosis (pyramidal tract injury, multiple sclerosis, myelopathy, encephalomyelitis), spastic paralysis, and other muscle dystonia-related Encephalopathy. Tolperisone hydrochloride also has antiviral activity.
In Vitro:Tolperisone (0-128 μM, 48 h) hydrochloride induces UPR-mediated cancer cell death by directly targeting LSD1, with IC50s of 10-40 μM[1]. Tolperisone inhibits LSD1 activity with an IC50 of 31.09 µM[1]. Tolperisone (100 μM, 48 h) induces cancer cell cycle arrest and apoptosis in AGS, A375, 8505C, and RKO cells[1]. Tolperisone (100 μM, 12 h) repolarizes M2 macrophages into M1 phenotype[1].
In Vivo:Tolperisone (25-100 mg/kg) shows antinociceptive effect in partial sciatic nerve ligation (pSNL) evoked neuropathic pain rats[2]. Tolperisone (60 mg/kg, once a day for 1 week) hydrochloride inhibits tumor growth in A375 cell-derived xenograft mouse model[1].
Hot selling product:Efavirenz | Pyrroloquinoline quinone (disodium salt) | Daxdilimab | GSK467 | 5-FAM | Peimine | KR-33493 | DCZ0415 | Caffeic acid | Halicin
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
References:
[1]. Jiang W, et al. Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1. Expert Opin Ther Targets. 2023 Jul-Dec;27(9):879-895. [Content Brief]
[2]. Lakatos PP, et al. The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action. Int J Mol Sci. 2022 Aug 24;23(17):9564. [Content Brief]
Brand introduction:
• MCE (MedChemExpress) has a global exclusive compound library of more than 200 kinds, and we are committed to providing the most comprehensive range of high-quality small molecule active compounds for scientific research customers around the world;
• More than 50,000 highly selective inhibitors and agonists are involved in various popular signaling pathways and disease areas;
• The products cover a variety of recombinant proteins, peptides, commonly used kits, more PROTAC, ADC and other characteristic products, widely used in new drug research and development, life science and other scientific research projects;
• Provide virtual screening, ion channel screening, metabolomics analysis detection analysis, drug screening and other professional technical services;
• It has a professional experimental center and strict quality control and verification system;
• Provide LC/MS, NMR, HPLC, chiral analysis, elemental analysis and other quality inspection reports to ensure the high purity and high quality of products;
• The biological activity of the products has been verified by the experiments of customers in various countries;
• A variety of top journals such as Nature, Cell, Science and pharmaceutical patents have included the scientific research results of MCE customers;
• Our professional team tracks the latest pharmaceutical and life science research and provides you with the latest active compounds in the world;
• It has established long-term cooperation with the world's major pharmaceutical companies and well-known scientific research institutions。